Category

Press Releases

Press Releases
August 28, 2020

The Insides Company Promoted to NZTE Focus 700

Press Release Source: The Insides Company Limited On: Friday 28 August 2020 Companies: The Insides Company Limited, New Zealand Trade and Enterprise The Insides Company (Insides Co.), a provider of innovative products for patients with intestinal failure, is pleased to be working with New Zealand Trade and Enterprise (NZTE) as a Focus 700 (F700) client. This announcement comes after NZTE…
Read More
Press Releases
August 28, 2020

University of Auckland Researchers Using The Insides System in Randomised Controlled Trial

Press Release Source: The Insides Company Limited On: Wednesday 19 August 2020 - Auckland Companies: The Insides Company Limited The Insides Company’s premier chyme reinfusion device, The Insides™ Systemfi, has been selected by researchers at the University of Auckland for a pivotal clinical trial. For patients with temporary ileostomies, fluid and nutrient loss is a serious side effect. The Insides…
Read More
Press Releases
April 20, 2020

The Insides Company’s Chyme Reinfusion System features in latest British Journal of Surgery Article

Press Release Source: The Insides Company Limited On: 9:00am Auckland, Monday 20th April 2020 Companies: The Insides Company Limited The Insides Company is delighted to announce the recent publication of the article, “Novel chyme reinfusion device for gastrointestinal fistulas and stomas: feasibility study” under the British Journal of Surgery (BJS), featuring the company’s therapeutic chyme reinfusion solution for the management…
Read More
NewsPress Releases
February 1, 2020

The InsidesTM Systemfi Cleared for Sale

The Insides™ Systemfi Now Commercially Available in the UK and EU   February 2020 The Insides Company is pleased to announce that The Insides™ Systemfi, an effective chyme reinfusion treatment for enteroatmospheric fistulas and high output enterostomies, is now cleared for sale and commercially available in the United Kingdom and Europe. This critical commercial milestone follows our ISO 13485 certification and…
Read More
Press Releases
January 30, 2020

The Insides Company Receives ISO 13485 Certification and CE Mark Approval for Chyme Reinfusion Devices

Press Release Source: The Insides Company Limited On: Friday, 31 January 2020 - Auckland The Insides Company has received ISO 13485 certification and CE mark approval for its chyme reinfusion therapeutic medical device solution. These certifications and approvals mean the device is now cleared for marketing in Europe and the United Kingdom. The Insides Company received the ISO 13485 certification following…
Read More
Press Releases
December 13, 2019

The Insides Company Rebranded from Surgical Design Studio

Press Release Source: The Insides Company Limited On: Friday 13 December 2019 - Auckland Companies: The Insides Company Limited, Surgical Design Studio Surgical Design Studio, a company developing a chyme reinfusion medical device, announces the complete rebranding to The Insides Company. This rebranding includes a new name, logo, and website. The rebranding initiative reflects the company’s vision to become a global leader in…
Read More
Press Releases
June 10, 2019

The Insides Company Granted Breakthrough Device Designation

Press Release Source: The Insides Company Limited On: Monday 10 June 2019 - Auckland Companies: The Insides Company Limited The Insides Company (Insides Co.), a provider of innovative products for patients with intestinal failure, announces its medical devices have been granted the Breakthrough Device Designation by the United States Food and Drug Administration (FDA). The Insides Company appears to be…
Read More
Press Releases
May 8, 2019

The Insides Company Appoints Commercialisation CEO

Press Release Source: The Insides Company Limited On: 4:00 PM, Wednesday 8 May 2019 - Auckland Companies: The Insides Company Limited The Insides Company (Insides Co.), a provider of innovative medical devices for intestinal failure patients, announces the appointment of Garth Sutherland as Chief Executive Officer to lead the company in its commercialisation phase of development. Garth Sutherland has 30…
Read More